Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.
Marcus Lind, Christoph Nowak, Ulf Hannelius, Rosaura Casas, Johnny Ludvigsson, Zdenek Sumnik, Ragnar Hanas, Sara Puente-Marin, Fabricia Dietrich, Stepanka Pruhova, Theo Sas, Marta Ferrer Lozano, Ana Gómez-Gila, Maria Clemente-León, Cristina Hernandez, Jeanette Wahlberg, MariSol Ruiz de Adana, Maria A Martínez-Brocca, Itxaso Rica, Elena Lundberg, Lía Nattero-Chavez, Terezie Pelikanova
The Journal of clinical endocrinology and metabolism 2022;107(9):2644-2651